secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-08-28T23:59:59+00:00
Accession:  0001601830-24-000140
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evotec commits ~11% Exscientia shares to Recursion deal; total committed ~53%
-----------------------------------------------------------------------------

- Evotec SE, holding ~11% of Exscientia shares, executed irrevocable undertaking on Aug 28 to vote in favor of Recursion acquisition.
- Combined with prior undertakings from August 8, shareholders holding ~53% of Exscientia now committed to support the deal.
- The transaction is structured as a scheme of arrangement under UK Companies Act, with Recursion acquiring all Exscientia share capital.
- Irrevocable undertaking prohibits Evotec from accepting competing offers or taking actions that impede the deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000140/0001601830-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000140/rxrx-20240828.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer